1. Home
  2. WVE vs LILA Comparison

WVE vs LILA Comparison

Compare WVE & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • LILA
  • Stock Information
  • Founded
  • WVE 2012
  • LILA 2017
  • Country
  • WVE Singapore
  • LILA Bermuda
  • Employees
  • WVE N/A
  • LILA N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • LILA Cable & Other Pay Television Services
  • Sector
  • WVE Health Care
  • LILA Telecommunications
  • Exchange
  • WVE Nasdaq
  • LILA Nasdaq
  • Market Cap
  • WVE 1.7B
  • LILA 1.4B
  • IPO Year
  • WVE 2015
  • LILA N/A
  • Fundamental
  • Price
  • WVE $7.74
  • LILA $6.34
  • Analyst Decision
  • WVE Strong Buy
  • LILA Buy
  • Analyst Count
  • WVE 11
  • LILA 2
  • Target Price
  • WVE $22.00
  • LILA $7.90
  • AVG Volume (30 Days)
  • WVE 1.3M
  • LILA 285.8K
  • Earning Date
  • WVE 03-04-2025
  • LILA 05-06-2025
  • Dividend Yield
  • WVE N/A
  • LILA N/A
  • EPS Growth
  • WVE N/A
  • LILA N/A
  • EPS
  • WVE N/A
  • LILA N/A
  • Revenue
  • WVE $108,302,000.00
  • LILA $4,456,900,000.00
  • Revenue This Year
  • WVE N/A
  • LILA $4.36
  • Revenue Next Year
  • WVE $33.28
  • LILA $2.90
  • P/E Ratio
  • WVE N/A
  • LILA N/A
  • Revenue Growth
  • WVE N/A
  • LILA N/A
  • 52 Week Low
  • WVE $4.25
  • LILA $5.94
  • 52 Week High
  • WVE $16.74
  • LILA $10.82
  • Technical
  • Relative Strength Index (RSI)
  • WVE 31.52
  • LILA 39.47
  • Support Level
  • WVE $9.43
  • LILA $6.50
  • Resistance Level
  • WVE $10.91
  • LILA $6.87
  • Average True Range (ATR)
  • WVE 0.63
  • LILA 0.20
  • MACD
  • WVE -0.18
  • LILA -0.04
  • Stochastic Oscillator
  • WVE 3.21
  • LILA 9.66

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: